(R)-Pyrrolidine-2-carbonitrile Hydrochloride - CAS 675602-84-3
Catalog: |
BB033325 |
Product Name: |
(R)-Pyrrolidine-2-carbonitrile Hydrochloride |
CAS: |
675602-84-3 |
Synonyms: |
(2R)-2-pyrrolidinecarbonitrile;hydrochloride; (2R)-pyrrolidine-2-carbonitrile;hydrochloride |
IUPAC Name: | (2R)-pyrrolidine-2-carbonitrile;hydrochloride |
Description: | (R)-Pyrrolidine-2-carbonitrile Hydrochloride has been used as a reactant for the synthesis of N-pyrrolidinylcarbonyl containging radiohalogen compounds for radiotherapy. |
Molecular Weight: | 132.59 |
Molecular Formula: | C5H9ClN2 |
Canonical SMILES: | C1CC(NC1)C#N.Cl |
InChI: | InChI=1S/C5H8N2.ClH/c6-4-5-2-1-3-7-5;/h5,7H,1-3H2;1H/t5-;/m1./s1 |
InChI Key: | QSJTUXCBPTVKQZ-NUBCRITNSA-N |
MDL: | MFCD03426407 |
LogP: | 1.39278 |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]; H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H335 (100%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation] |
Precautionary Statement: | P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
EP-3352750-A1 | Cyclohexene derivative, preparation method thereof, and pharmaceutical composition for preventing or treating metabolic disease comprising the same as active ingredient | 20151104 |
KR-101763533-B1 | Cyclohexene derivative, preparation method thereof, and pharmaceutical composition for preventing or treating metabolic disease comprising the same as active ingredient | 20151104 |
KR-20170053118-A | Cyclohexene derivative, preparation method thereof, and pharmaceutical composition for preventing or treating metabolic disease comprising the same as active ingredient | 20151104 |
US-2018318274-A1 | Cyclohexene derivative, preparation method thereof, and pharmaceutical composition for preventing or treating metabolic disease comprising the same as active ingredient | 20151104 |
WO-2017078352-A1 | Cyclohexene derivative, preparation method thereof, and pharmaceutical composition for preventing or treating metabolic disease comprising the same as active ingredient | 20151104 |
Complexity: | 99.9 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 2 |
Defined Atom Stereocenter Count: | 1 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 132.045426 |
Formal Charge: | 0 |
Heavy Atom Count: | 8 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 2 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 132.045426 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 35.8 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Nitrogen Compounds
Customers Also Viewed
-
[1866059-82-6]
1,1,2,2-Tetrafluoro-3-methylsulfonylpropane
-
[132182-92-4]
Pentane, 1,1,1,2,2,3,4,5,5,5-decafluoro-3-methoxy-4-(trifluoromethyl)-
-
[730-46-1]
5-Dodecyldihydro-2(3H)-Furanone
-
[1070-68-4]
Heptanoicacid, 5-methyl-
-
[55382-52-0]
Methyl Divarinolcarboxylate
-
[433335-00-3]
N-Boc-(tosyl)methylamine
INDUSTRY LEADERS TRUST OUR PRODUCTS